Stenocare A/S (CPH:STENO)
0.452
-0.040 (-8.13%)
Feb 21, 2025, 4:26 PM CET
Stenocare Company Description
Stenocare A/S cultivates, produces, imports, sells, and distributes prescription-based medical cannabis products to patients in the Danish and European markets.
It offers medical cannabis oil products. Stenocare A/S was incorporated in 2017 and is based in Randers, Denmark.
Stenocare A/S

Country | Denmark |
Founded | 2017 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
CEO | Thomas Schnegelsberg |
Contact Details
Address: Nyholmsvej 4 Randers, Capital Region of Denmark 8930 Denmark | |
Phone | 45 31 77 00 60 |
Website | stenocare.dk |
Stock Details
Ticker Symbol | STENO |
Exchange | Copenhagen Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | DKK |
ISIN Number | DK0061078425 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Thomas Skovlund Schnegelsberg | Chief Executive Officer, Co-Founder and Member of Executive Board |
Rolf Steno Petersen | Co-Founder, Chief Commercial Officer and Director |
Soren Kjaer | Co-Founder and Chief Operating Officer |
Peter Bugge Johansen | Chief Financial Officer |